ANALYSIS OF RISK FACTORS IN THE DEVELOPMENT OF POLYCYSTIC OVARY SYNDROME

Authors

Keywords:

polycystic ovary syndrome, risk factors, hyperinsulinaemia, prevention.

Abstract

 Polycystic ovary syndrome (PCOS) is one of the most common endocrine disorders among women of reproductive age, with an estimated prevalence of approximately 6–13% [4]. It is characterised by menstrual irregularities, hyperandrogenism, and infertility. In recent years, PCOS has increasingly been recognised not merely as a gynaecological condition but also as a metabolic disorder. Insulin resistance has been identified in many affected women, including those with a normal body weight [2, 3]. This condition is associated with an increased risk of type 2 diabetes mellitus and cardiovascular disease. Therefore, understanding the relationship between PCOS and metabolic disturbances is essential for early diagnosis and appropriate clinical management.

References

1.Teede H.J., Tay C.T., Laven J.J.E. et al. Recommendations from the 2023 international evidence-based guideline for the assessment and management of polycystic ovary syndrome. Hum Reprod. 2023;38(9):1655–1679.

2.Dunaif A. Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis. Endocr Rev. 1997;18(6):774–800.

3.Ortiqov B. B. ISHCHILARDA KASALLANISH VA UNING GIGIYENIK TAHLIL //ОСНОВЫ МЕДИЦИНЫ. – 2026. – Т. 1. – №. 11. – С. 188-190.

4.Azziz R., Woods K.S., Reyna R. et al. The prevalence and features of the polycystic ovary syndrome in an unselected population. J Clin Endocrinol Metab. 2004;89(6):2745–2753.

5.Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril. 2004;81(1):19–25.

6.Moran L.J., Misso M.L., Wild R.A., Norman R.J. Impaired glucose tolerance, type 2 diabetes and metabolic syndrome in polycystic ovary syndrome: a systematic review and meta-analysis. Hum Reprod Update. 2010;16(4):347–363.

7.Diamanti-Kandarakis E., Dunaif A. Insulin resistance and the polycystic ovary syndrome revisited: an update on mechanisms and implications. Endocr Rev. 2012;33(6):981–1030.

Downloads

Published

2026-10-31